Ceramides modulate cell-surface acetylcholine receptor levels

Biochimica et Biophysica Acta - Biomembranes

Volumn 1778, Issue 4, 2008, Pages 917-930

  Gallegos, C E ^a   Pediconi, M F ^a   Barrantes, F J ^a  

^a Instituto de Investigaciones Bioquimicas Bahia Blanca   (Argentina)

Author keywords

Ceramide; Nicotinic receptor; Protein traffic; Sphingomyelinase; Sphingosine

Indexed keywords

ALPHA BUNGAROTOXIN I 125; CERAMIDE; GREEN FLUORESCENT PROTEIN; NICOTINIC RECEPTOR; PHOSPHOPROTEIN PHOSPHATASE 2A; PROTEIN KINASE C ZETA; SPHINGOMYELIN PHOSPHODIESTERASE;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL LINE; CELL MEMBRANE; CELL SURFACE; CONTROLLED STUDY; CULTURE MEDIUM; ENZYME ACTIVATION; ENZYME ACTIVITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN STABILITY; PROTEIN TRANSPORT; RECEPTOR AFFINITY; TRANS GOLGI NETWORK;

ANIMALS; CATTLE; CERAMIDES; CHO CELLS; CRICETINAE; CRICETULUS; ENDOCYTOSIS; GOLGI APPARATUS; HUMANS; INTRACELLULAR SPACE; NYSTATIN; RECEPTORS, NICOTINIC; SPHINGOMYELIN PHOSPHODIESTERASE; SPHINGOSINE;

MURINAE; VESICULAR STOMATITIS VIRUS;

EID: 41249097331     PISSN: 00052736     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamem.2007.10.019     Document Type: Article

References (73)

1. Barrantes F.J. Modulation of nicotinic acetylcholine receptor function through the outer and middle rings of transmembrane domains. Curr. Opin. Drug. Discov. Devel. 6 (2003) 620-632
2. Barrantes F.J. Structural basis for lipid modulation of nicotinic acetylcholine receptor function. Brain Res. Rev. 47 (2004) 71-95
3. Barrantes F.J. Cholesterol effects on nicotinic acetylcholine receptor. J. Neurochem. 103 Suppl. 1 (2007) 72-80
4. Borroni V., Baier C.J., Lang T., Bonini I., White M.W., Garbus I., and Barrantes F.J. Cholesterol depletion activates rapid internalization of diffraction-limited acetylcholine receptor domains at the cell membrane. Mol. Membr. Biol. 24 (2007) 1-15
5. Kellner R., Baier C.J., Willig K.I., Hell S.W., and Barrantes F.J. Nanoscale organization of nicotinic acetylcholine receptors revealed by STED microscopy. Neuroscience 144 (2007) 135-143
6. Pediconi M.F., Gallegos C.E., De los Santos E.B., and Barrantes F.J. Metabolic cholesterol depletion hinders cell-surface trafficking of the nicotinic acetylcholine receptor. Neuroscience 128 (2004) 239-249
7. Roccamo A.M., Pediconi M.F., Aztiria E., Zanello L.P., Wolstenholme A., and Barrantes F.J. Cells defective in sphingolipids biosynthesis express low amount of muscle nicotinic acetylcholine receptor. Eur. J. Neurosci. 11 (1999) 1615-1623
8. Baier C.J., and Barrantes F.J. Sphingolipids are necessary for nicotinic acetylcholine receptor export in the early secretory pathway. J. Neurochem. 101 (2007) 1072-1084
9. Proszinski T.J., Klemm R.W., Gravert M., Hsu P.P., Gloor Y., Wagner J., Kozak K., Grabner H., Walzer K., Bagnat M., Simons K., and Walch-Solimena C. A genome-wide visual screen reveals a role for sphingolipids and ergosterol in cell surface delivery in yeast. PNAS 102 (2005) 17981-17986
10. Rosenwald A.G., Machamer C.E., and Pagano R.E. Effects of a sphingolipid synthesis inhibitor on membrane transport through the secretory pathway. Biochemistry 31 (1992) 3581-3590
11. Spiegel S., Foster D., and Kolesnick R. Signal transduction through lipid second messengers. Curr. Opin. Cell Biol. 8 (1996) 159-167
12. Dobrowsky R.T., Kamibayashi C., Mumby M.C., and Hannun Y.A. Ceramide activates heterotrimeric protein phosphatase 2A. J. Biol. Chem. 268 (1993) 15523-15530
13. Liu J., Mathias S., Yang Z., and Kolesnick R.N. Renaturation and TNFα stimulation of a 97 kDa ceramide-activated protein phosphatase. J. Biol. Chem. 269 (1994) 3047-3052
14. Gulbins E., Coggeshall K.M., Baier G., Telford D., Langlet C., Baier-Bitterlich G., Bonnefoy-Berard N., Burn P., Wittinghofer A., and Altman A. Direct stimulation of Vav-guanine nucleotide exchange activity for ras by phorbol esters and diglycerides. Mol. Cell. Biol. 14 (1994) 4749-4758
15. Lozano J., Berra E., Municio M.M., Díaz-Mecco M.T., Domínguez I., Sanz L., and Moscat J. Protein kinase C isoform is critical for kappa B-dependent promoter activation by sphingomyelinase. J. Biol. Chem. 269 (1994) 19200-19202
16. Muller G., Ayoub M., Storz P., Rannecke J., Fabbro D., and Pfizenmaier K. PKC ξ is a molecular switch in signal transduction of TNFα, bifunctionally regulated by ceramide and arachidonic acid. EMBO J. 14 (1995) 1961-1969
17. Ruvolo P.P. Intracellular signal transduction pathways activated by ceramide and its metabolites. Pharmacol. Res. 47 (2003) 383-392
18. Simons K., and Ikonen E. Functional rafts in cell membranes. Nature 387 (1997) 569-572
19. Simons K., and Toomre D. Lipid rafts and signal transduction. Nat. Rev., Mol. Cell Biol. 1 (2000) 31-39
20. Edidin M. The state of lipid rafts: from model membranes to cells. Annu. Rev. Biophys. Biomol. Struct. 32 (2003) 257-283
21. Bjorkqvist Y.J.E., Nyholm T.K.M., Slotte J.P., and Ramsted B. Domain formation and stability in complex lipid bilayers as reported by cholestatrienol. Biophys. J. 88 (2005) 4054-4063
22. London M., and London E. Ceramide selectively displaces cholesterol from ordered domains (rafts): implications for lipid raft structure and function. J. Biol. Chem. 279 (2004) 9997-10004
23. Rosenwald A.G., and Pagano R.E. Inhibition of glycoprotein traffic through the secretory pathway by ceramide. J. Biol. Chem. 268 (1993) 4577-4579
24. Patrick J., McMillan J., Wolfson H., and O'Brien J.C. Acetylcholine receptor metabolism in a nonfusing muscle cell line. J. Biol. Chem. 252 (1977) 143-153
25. Green W.N., and Claudio T. Acetylcholine receptor assembly: subunit folding and oligomerization occur sequentially. Cell 74 (1993) 57-69
26. Schmidt J., and Raftery M.A. A simple assay for the study of solubilized acetylcholine receptors. Anal. Biochem. 52 (1973) 349-354
27. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. A protein determination by the Folin-phenol reagent. J. Biol. Chem. 193 (1951) 265-275
28. Yildiz D., Ercal N., and Armstrong D.W. Nicotine enantiomers and oxidative stress. Toxicology 130 (1998) 155-165
29. Fujii Y., Nomura T., Kanzawa H., Kameyama M., Yamanaka H., Akita M., Setsu K., and Okamoto K. Purification and characterization of enterotoxin produced by Aeromonas sobria. Microbiol. Immunol. 42 (1998) 703-714
30. Lipsky N.G., and Pagano R.E. Sphingolipid metabolism in cultured fibroblast: microscopic and biochemical studies employing a fluorescent ceramide analogue. Proc. Natl. Acad. Sci. U. S. A. 80 (1983) 2608-2612
31. Loidl A., Claus R., Deigner H.P., and Hermetter A. High-precision fluorescence assay for sphingomyelinase activity of isolated enzymes and cell lysates. J. Lipid Res. 43 (2002) 815-823
32. Nakai Y., Sakurai Y., Yamaji A., Asou H., Umeda M., Uyemura K., and Itoh K. Lysenin-sphingomyelin binding at the surface of oligodendrocyte lineage cells increases during differentiation in vitro. J. Neurosci. Res. 62 (2000) 521-529
33. Kiyokawa E., Baba T., Otsuka N., Makino A., Ohno S., and Kobayashi T. Spatial and functional heterogeneity of sphingolipid-rich membrane domains. J. Biol. Chem. 280 (2005) 24072-24084
34. Zha X., Pierini L.M., Leopold P.L., Skiba P.J., Tabas I., and Maxfield F.R. Sphingomyelinase treatment induces ATP-independent endocytosis. J. Cell Biol. 140 (1998) 39-47
35. Sot J., Goñi F.M., and Alonso A. Molecular associations and surface-active properties of short- and long-N-acyl chain ceramides. Biochim. Biophys. Acta 1711 (2005) 12-19
36. van Blitterswijk W.J., van der Luit A.H., Veldman R.J., Verheij M., and Borst J. Ceramide: second messenger or modulator of membrane structure and dynamics?. Biochem. J. 369 (2003) 199-211
37. Kuhle V., Abrahams G.L., and Hensel M. Intracellular Salmonella enterica redirect exocytic transport processes in a Salmonella pathogenicity island 2-dependent manner. Traffic 76 (2006) 716-730
38. Hu W., Xu R., Zhang G., Jin J., Szulc Z.M., Bielawski J., Hannun Y.A., Obeid L.M., and Mao C. Golgi fragmentation is associated with ceramide-induced cellular effects. Mol. Biol. Cell. 16 (2005) 1555-1567
39. Mackenzie J.M., Jones M.K., and Westaway E.G. Markers for trans-Golgi membranes and the intermediate compartment localize to induced membranes with distinct replication functions in flavivirus-infected cells. J. Virol. 73 (1999) 9555-9567
40. Schaub B.E., Berger B., Berger E.G., and Rohrer J. Transition of galactosyltransferase 1 from trans-Golgi cisterna to the trans-Golgi network is signal mediated. Mol. Biol. Cell 17 (2006) 5153-5162
41. Vandenbulcke F., Nouel D., Vincent J.P., Mazella J., and Beaudet A. Ligand-induced internalization of neurotensin in transfected COS-7 cells: differential intracellular trafficking of ligand and receptor. J. Cell Sci. 113 (2000) 2963-2975
42. Taha T.A., Hannun Y.A., and Obeid L.M. Sphingosine kinase: biochemical and cellular regulation and role in disease. J. Biochem. Mol. Biol. 39 (2006) 113-131
43. Hannun Y.A. Functions of ceramide in coordinating cellular responses to stress. Science, 274 (1996) 1855-18599
44. Ross A.F., Rapuano M., Schmidt J.H., and Prives J.M. Phosphorylation and assembly of nicotinic acetylcholine receptor subunits in cultured chick muscle cells. J. Biol. Chem. 262 (1987) 14640-14647
45. Sadasivam G., Willmann R., Lin S., Erb-Vogtli S., Kong X.C., Ruegg M.A., and Fuhrer C. Src-family kinases stabilize the neuromuscular synapse in vivo via protein interactions, phosphorylation, and cytoskeletal linkage of acetylcholine receptors. J. Neurosci. 25 (2005) 10479-10493
46. Bruneau E.G., and Akaaboune M. The dynamics of recycled acetylcholine receptors at the neuromuscular junction in vivo. Development. 133 (2006) 4485-4493
47. Lanuza M.A., Gizaw R., Viloria A., Gonzalez C.M., Besalduch N., Dunlap V., Tomas J., and Nelson P.G. Phosphorylation of the nicotinic acetylcholine receptor in myotube-cholinergic neuron cocultures. J. Neurosci. Res. 83 (2006) 1407-1414
48. Haystead T.A., Sim A.T.R., Carling D., Honnor R.C., Tsukitani Y., Cohen P., and Hardie D.G. Effects of the tumor promoter okadaic acid on intracellular protein phosphorylation and metabolism. Nature 337 (1989) 78-81
49. Bourbon N.A., Yun J., and Kester M. Ceramide directly activates protein kinase C zeta to regulate a stress-activated protein signaling complex. J. Biol. Chem. 275 (2000) 35617-35623
50. Yamaji-Hasegawa A., Makino A., Baba T., Senoh Y., Kimura-Suda H., Sato S.B., Terada N., Ohno S., Kiyokawa E., Umeda M., and Kobayashi T. Oligomerization and pore formation of a sphingomyelin-specific toxin, lysenin. J. Biol. Chem. 278 (2003) 22762-22770
51. Pagano R.E., Martin O.C., Kang H.C., and Haugland R.P. A novel fluorescent ceramide analogue for studying membrane traffic in animal cells: accumulation at the Golgi apparatus results in altered spectral properties of the sphingolipid precursor. J. Cell Biol. 113 (1991) 1267-1279
52. Brown D.A., and London E. Functions of lipid rafts in biological membranes. Annu. Rev. Cell Dev. Biol. 14 (1998) 111-136
53. Slotte J.P., and Bierman E.L. Depletion of plasma membrane sphingomyelin rapidly alters the distribution of cholesterol between plasma membranes and intracellular cholesterol pools in cultured fibroblast. Biochem. J. 250 (1988) 653-658
54. Ridgway N.D. Interactions between metabolism and intracellular distribution of cholesterol and sphingomyelin. Biochim. Biophys. Acta 1484 (2000) 129-141
55. Tewary P., Veena K., Pucadyil T.J., Chattopadhyay A., and Madhubala R. The sterol-binding antibiotic nystatin inhibits entry of non-opsonized Leishmania donovani into macrophages. Biochem. Biophys. Res. Commun. 339 (2006) 661-666
56. Hannun Y.A. The sphingomyelin cycle and the second messenger function of ceramide. J. Biol. Chem. 26 (1994) 3125-3128
57. Xu X., Bittman R., Duportall G., Heissler D., Vilcheze C., and London E. Effects of the structure of natural sterols and sphingolipids on the formation of ordered sphingolipids/sterol domains (raft), comparison of cholesterol to plant, fungal, and disease-associated sterols and comparison of sphingomyelin, cerebrosides, and ceramide. J. Biol. Chem. 276 (2001) 33540-33546
58. Wang T.Y., and Silvius J.R. Sphingolipid partitioning into ordered domains in cholesterol-free and cholesterol-containing lipid bilayers. Biophys. J. 84 (2003) 367-378
59. Bock J., Szabo I., Gamper N., Adams C., and Gulbins E. Ceramide inhibits the potassium channel Kv1.3 by the formation of membrane platforms. Biochem. Biophys. Res. Commun. 305 (2003) 890-897
60. Bollinger C.R., Teichgraber V., and Gulbins E. Ceramide-enriched membrane domains. Biochim. Biophys. Acta 1746 (2005) 284-294
61. Silva L., de Almeida R.F., Fedorov A., Matos A.P., and Prieto M. Ceramide-platform formation and -induced biophysical changes in a fluid phospholipid membrane. Mol. Membr. Biol. 23 (2006) 137-148
62. Ardail D., Popa I., Bodennec J., Famy C., Louisot P., and Portoukalian J. Subcellular distribution and metabolic fate of exogenous ceramides taken up by HL-60 cells. Biochim. Biophys. Acta 1583 (2002) 305-310
63. Ridgway N.D., and Merrian D.L. Metabolism of short chain ceramide and dihidroceramide analogues in Chinese hamster ovary (CHO) cells. Biochim. Biophys. Acta 1256 (1995) 57-70
64. Furuya S., Mitoma J., Makino A., and Hirabayashi Y. Ceramide and its interconvertible metabolite sphingosine function as indispensable lipid factors involved in survival and dendritic differentiation of cerebellar Purkinje cells. J. Neurochem. 71 (1998) 366-377
65. Venkataraman K., and Futerman A.H. Comparison of the metabolism of l-erythro- and l-threo-sphinganines and ceramides in cultured cells and in subcellular fractions. Biochim. Biophys. Acta 1530 (2001) 219-226
66. Harder T., Scheiffele P., Verkade P., and Simons K. Lipid domain structure of the plasma membrane revealed by patching of membrane components. J. Cell Biol. 141 (1998) 929-942
67. Luan Y., and Griffiths H.R. Ceramides reduce CD36 cell surface expression and oxidised LDL uptake by monocytes and macrophages. Arch. Biochem. Biophys. 450 (2006) 89-99
68. Abousalham A., Hobman T.C., Dewald J., Garbutt M., and Brindley D.N. Cell-permeable ceramides preferentially inhibit coated vesicle formation and exocytosis in Chinese hamster ovary compared with Madin-Darby canine kidney cells by preventing the membrane association of ADP-ribosylation factor. Biochem. J. 361 (2002) 653-661
69. Bonini I.C., Antollini S.S., Gutierrez-Merino C., and Barrantes F.J. Sphingomyelin composition and physical asymmetries in native acetylcholine receptor-rich membranes. Eur. Biophys. J. 31 (2002) 417-427
70. Heron D.S., Shinitzkyt M., Hershkowitz M., and Samuel D. Lipid fluidity markedly modulates the binding of serotonin to mouse brain membranes. Proc. Natl. Acad. Sci. U. S. A. 77 (1980) 7463-7467
71. Wang T.Y., and Silvius J.R. Different sphingolipids show differential partitioning into sphingolipid/cholesterol-rich domains in lipid bilayers. Biophys. J. 79 (2000) 1478-1489
72. Gidwani A., Brown H.A., Holowka D., and Baird B. Disruption of lipid order by short-chain ceramides correlates with inhibition of phospholipase D and downstream signaling by Fce{open}RI. J. Cell Sci. 116 (2003) 3177-3187
73. Nybond S., Bjorkqvist Y.J., Ramstedt B., and Slotte J.P. Acyl chain length affects ceramide action on sterol/sphingomyelin-rich domains. Biochim. Biophys. Acta 1718 (2005) 61-66